177 related articles for article (PubMed ID: 38316201)
1. IL-10-producing regulatory cells impact on celiac disease evolution.
Passerini L; Amodio G; Bassi V; Vitale S; Mottola I; Di Stefano M; Fanti L; Sgaramella P; Ziparo C; Furio S; Auricchio R; Barera G; Di Nardo G; Troncone R; Gianfrani C; Gregori S
Clin Immunol; 2024 Mar; 260():109923. PubMed ID: 38316201
[TBL] [Abstract][Full Text] [Related]
2. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells.
Gianfrani C; Levings MK; Sartirana C; Mazzarella G; Barba G; Zanzi D; Camarca A; Iaquinto G; Giardullo N; Auricchio S; Troncone R; Roncarolo MG
J Immunol; 2006 Sep; 177(6):4178-86. PubMed ID: 16951383
[TBL] [Abstract][Full Text] [Related]
3. Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.
Anderson RP; Goel G; Hardy MY; Russell AK; Wang S; Szymczak E; Zhang R; Goldstein KE; Neff K; Truitt KE; Williams LJ; Dzuris JL; Tye-Din JA
Clin Exp Immunol; 2021 Jun; 204(3):321-334. PubMed ID: 33469922
[TBL] [Abstract][Full Text] [Related]
4. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease.
Sapone A; Lammers KM; Mazzarella G; Mikhailenko I; Cartenì M; Casolaro V; Fasano A
Int Arch Allergy Immunol; 2010; 152(1):75-80. PubMed ID: 19940509
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-mediated gliadin degradation and concomitant IL-27 production drive IL-10- and IFN-γ-secreting Tr1-like-cell differentiation in a murine model for gluten tolerance.
van Leeuwen MA; Costes LMM; van Berkel LA; Simons-Oosterhuis Y; du Pré MF; Kozijn AE; Raatgeep HC; Lindenbergh-Kortleve DJ; van Rooijen N; Koning F; Samsom JN
Mucosal Immunol; 2017 May; 10(3):635-649. PubMed ID: 27579860
[TBL] [Abstract][Full Text] [Related]
7. Vaccination and other antigen-specific immunomodulatory strategies in celiac disease.
Rossi M
Dig Dis; 2015; 33(2):282-289. PubMed ID: 25925936
[TBL] [Abstract][Full Text] [Related]
8. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
[TBL] [Abstract][Full Text] [Related]
9. Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease.
Camarca A; Auricchio R; Picascia S; Fierro O; Maglio M; Miele E; Malamisura B; Greco L; Troncone R; Gianfrani C
Pediatr Allergy Immunol; 2017 Jun; 28(4):362-369. PubMed ID: 28339124
[TBL] [Abstract][Full Text] [Related]
10. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
Freitag TL; Podojil JR; Pearson RM; Fokta FJ; Sahl C; Messing M; Andersson LC; Leskinen K; Saavalainen P; Hoover LI; Huang K; Phippard D; Maleki S; King NJC; Shea LD; Miller SD; Meri SK; Getts DR
Gastroenterology; 2020 May; 158(6):1667-1681.e12. PubMed ID: 32032584
[TBL] [Abstract][Full Text] [Related]
11. Microbial transglutaminase: A biotechnological tool to manage gluten intolerance.
Luongo D; Maurano F; Bergamo P; Rossi M
Anal Biochem; 2020 Mar; 592():113584. PubMed ID: 31953047
[TBL] [Abstract][Full Text] [Related]
12. T cells in peripheral blood after gluten challenge in coeliac disease.
Anderson RP; van Heel DA; Tye-Din JA; Barnardo M; Salio M; Jewell DP; Hill AV
Gut; 2005 Sep; 54(9):1217-23. PubMed ID: 16099789
[TBL] [Abstract][Full Text] [Related]
13. Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.
Ontiveros N; Tye-Din JA; Hardy MY; Anderson RP
Clin Exp Immunol; 2014 Feb; 175(2):305-15. PubMed ID: 24192268
[TBL] [Abstract][Full Text] [Related]
14. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.
Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603
[TBL] [Abstract][Full Text] [Related]
15. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease.
Ciccocioppo R; Camarca A; Cangemi GC; Radano G; Vitale S; Betti E; Ferrari D; Visai L; Strada E; Badulli C; Locatelli F; Klersy C; Gianfrani C; Corazza GR
Cytotherapy; 2014 Aug; 16(8):1080-91. PubMed ID: 24831843
[TBL] [Abstract][Full Text] [Related]
17. Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria.
Sjöberg V; Sandström O; Hedberg M; Hammarström S; Hernell O; Hammarström ML
PLoS One; 2013; 8(1):e53414. PubMed ID: 23326425
[TBL] [Abstract][Full Text] [Related]
18. Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications.
Picascia S; Mandile R; Auricchio R; Troncone R; Gianfrani C
Nutrients; 2015 Dec; 7(12):10020-31. PubMed ID: 26633487
[TBL] [Abstract][Full Text] [Related]
19. Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes.
Porpora M; Conte M; Lania G; Bellomo C; Rapacciuolo L; Chirdo FG; Auricchio R; Troncone R; Auricchio S; Barone MV; Nanayakkara M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216089
[TBL] [Abstract][Full Text] [Related]
20. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
